First Trust Advisors’s Qiagen QGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.6M | Sell |
265,810
-4,234
| -2% | -$200K | 0.01% | 1071 |
|
|
2025
Q4 | $12.1M | Buy |
270,044
+185,298
| +219% | +$8.57M | 0.01% | 1030 |
|
|
2025
Q3 | $3.79M | Buy |
84,746
+9,028
| +12% | +$432K | ﹤0.01% | 1524 |
|
|
2025
Q2 | $3.64M | Buy |
+75,718
| New | +$3.29M | ﹤0.01% | 1531 |
|
|
2025
Q1 | – | Sell |
-8,555
| Closed | -$392K | – | 2605 |
|
|
2024
Q4 | $392K | Sell |
8,555
-347,755
| -98% | -$15.6M | ﹤0.01% | 2319 |
|
|
2024
Q3 | $16.7M | Sell |
356,310
-937
| -0.3% | -$42.7K | 0.02% | 883 |
|
|
2024
Q2 | $15.1M | Buy |
357,247
+11,994
| +3% | +$526K | 0.02% | 883 |
|
|
2024
Q1 | $15.3M | Sell |
345,253
-959,715
| -74% | -$43.7M | 0.02% | 887 |
|
|
2023
Q4 | $60.1M | Buy |
1,304,968
+136,431
| +12% | +$5.8M | 0.07% | 388 |
|
|
2023
Q3 | $50.2M | Sell |
1,168,537
-242,036
| -17% | -$11.3M | 0.06% | 420 |
|
|
2023
Q2 | $67.4M | Buy |
1,410,573
+66,150
| +5% | +$3.19M | 0.08% | 376 |
|
|
2023
Q1 | $65.5M | Sell |
1,344,423
-52,837
| -4% | -$2.69M | 0.08% | 383 |
|
|
2022
Q4 | $73.9M | Buy |
1,397,260
+154,362
| +12% | +$7.61M | 0.09% | 348 |
|
|
2022
Q3 | $54.4M | Sell |
1,242,898
-204,863
| -14% | -$10.1M | 0.07% | 424 |
|
|
2022
Q2 | $72.5M | Buy |
1,447,761
+200,755
| +16% | +$9.79M | 0.09% | 326 |
|
|
2022
Q1 | $64.8M | Sell |
1,247,006
-54,645
| -4% | -$2.82M | 0.07% | 423 |
|
|
2021
Q4 | $76.7M | Sell |
1,301,651
-281,685
| -18% | -$16.1M | 0.07% | 340 |
|
|
2021
Q3 | $86.8M | Buy |
1,583,336
+65,995
| +4% | +$3.67M | 0.09% | 269 |
|
|
2021
Q2 | $77.8M | Buy |
1,517,341
+177,472
| +13% | +$9.17M | 0.08% | 314 |
|
|
2021
Q1 | $69.2M | Buy |
1,339,869
+161,560
| +14% | +$8.88M | 0.08% | 331 |
|
|
2020
Q4 | $66M | Sell |
1,178,309
-265,016
| -18% | -$14.1M | 0.09% | 304 |
|
|
2020
Q3 | $80M | Sell |
1,443,325
-72,365
| -5% | -$3.75M | 0.13% | 194 |
|
|
2020
Q2 | $68.8M | Buy |
1,515,690
+19,548
| +1% | +$875K | 0.12% | 211 |
|
|
2020
Q1 | $66M | Sell |
1,496,142
-425,799
| -22% | -$16.6M | 0.15% | 180 |
|
|
2019
Q4 | $68.9M | Buy |
1,921,941
+476,898
| +33% | +$17.7M | 0.12% | 238 |
|
|
2019
Q3 | $50.5M | Sell |
1,445,043
-898,059
| -38% | -$34.5M | 0.1% | 293 |
|
|
2019
Q2 | $101M | Sell |
2,343,102
-189,134
| -7% | -$7.84M | 0.19% | 124 |
|
|
2019
Q1 | $109M | Buy |
2,532,236
+160,249
| +7% | +$6.45M | 0.22% | 103 |
|
|
2018
Q4 | $86.6M | Sell |
2,371,987
-153,170
| -6% | -$5.69M | 0.21% | 94 |
|
|
2018
Q3 | $101M | Buy |
2,525,157
+913,998
| +57% | +$36.5M | 0.19% | 107 |
|
|
2018
Q2 | $61.8M | Buy |
+1,611,159
| New | +$59.3M | 0.13% | 160 |
|
|
2018
Q1 | – | Sell |
-1,118,215
| Closed | -$36.7M | – | 2363 |
|
|
2017
Q4 | $36.7M | Sell |
1,118,215
-152,298
| -12% | -$5.25M | 0.09% | 292 |
|
|
2017
Q3 | $42.4M | Buy |
1,270,513
+247,741
| +24% | +$8.54M | 0.11% | 209 |
|
|
2017
Q2 | $36.4M | Sell |
1,022,772
-30,950
| -3% | -$1.05M | 0.1% | 238 |
|
|
2017
Q1 | $32.4M | Buy |
+1,053,722
| New | +$32.5M | 0.09% | 269 |
|
Other funds holding QGEN
VCM
First Trust Advisors's QGEN Position: Q1 2026 in Review
First Trust Advisors reduced its Qiagen (QGEN) stake by 1.6% in Q1 2026, selling an estimated $200K and leaving 265,810 shares worth $10.6M. The position accounts for 0.01% of the portfolio, ranked #1071.
First Trust Advisors first reported a position in QGEN in Q1 2017 and has held it in 35 quarters since. The position peaked at $109M in Q1 2019. 343 funds tracked by Wall St. Rank hold QGEN as of Q1 2026.
- First Trust Advisors held 265,810 shares of Qiagen worth $10.6M as of Q1 2026.
- First Trust Advisors sold 4,234 Qiagen shares in Q1 2026, an estimated $200K.
- Qiagen made up 0.01% of First Trust Advisors's portfolio in Q1 2026, its #1071 holding.
- First Trust Advisors first reported a position in Qiagen in Q1 2017 and has held it in 35 quarters since.
- First Trust Advisors's Qiagen position peaked at $109M in Q1 2019.
- 343 funds tracked by Wall St. Rank held Qiagen as of Q1 2026.
Based on First Trust Advisors's 13F filing for Q1 2026, filed 13 May 2026.